Navigation Links
Synedgen Announces Effective Treatment Against Bacterial Biofilms in Minor Animal Species
Date:5/5/2013

acute dermal wounds including foot disease in minor species,” remarked Townsend. “The non-toxic nature of Synoplex is also beneficial in a large animal setting.”

Synoplex is available directly from Synedgen. For pricing and ordering information, please contact Synedgen at info(at)synedgen(dot)com.

About Synedgen

Synedgen Inc. is an innovative biopharmaceutical company focused on developing novel therapies and products through its proprietary biomaterials technology platform. Product development is targeted to specifically address unmet needs for therapies to treat inflammation, damage or infection at dermal, pulmonary and gastrointestinal surfaces.

Synedgen’s Corporate Headquarters, Research Laboratories and Manufacturing Facility are in Claremont CA. Additional information can be found at Synedgen’s web site at http://www.synedgen.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10700553.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Synedgen Announces Issuance of Patent to Optimize Animal Health
2. Synedgen’s Synoplex® Receives FDA Indexing for Use in the Treatment of Chronic Wounds in Pachyderms
3. Small Business Online SEO Class Enrolling Now, Announces JM Internet
4. Anthera Announces First Quarter 2013 Financial Report and Conference Call
5. Life Technologies Announces First Quarter 2013 Results
6. ETEX Corporation announces extended Supply Agreement with Knee Creations, LLC
7. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
8. BioLife Solutions Announces License Agreement
9. PRIM&R Announces Longtime Leader to Step Down
10. MiMedx Announces Record First Quarter 2013 Results
11. ViroPharma Announces First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... work by a Florida State University research team has ... your temperature, emit white light, and convert photon energy ... like a butterfly. , Biwu Ma, associate professor in ... FAMU-FSU College of Engineering, created the molecule in a ... discover that his creation has many other unique capabilities. ...
(Date:8/28/2014)... Earlier this month, a report was ... the U.S. Air Force on the performance of vehicles ... this type of fuel made from mustard seeds, offered ... to America’s Eco friendly future. In fact, every branch ... become independent of foreign oil over the next few ...
(Date:8/28/2014)... 2014 Whitehouse Laboratories is excited to ... with PTI Inspection Systems that will enable ... the art leak testing method development and validation programs ... available. As part of this agreement, Whitehouse Labs has ... Detection Instrument developed and manufactured by PTI. The ...
(Date:8/27/2014)... -- Rhythm, a biopharmaceutical company developing peptide therapeutics that ... metabolic disorders, announced today that it has filed a ... and Exchange Commission (SEC) relating to the proposed initial ... number of shares to be offered and the price ... Citigroup and Cowen and Company will act ...
Breaking Biology Technology:Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2
... Hosts Three Customer Audits, Continues Growth Strategy ... Industry-Leading Software Tools, MOUNTAIN VIEW, Calif., Dec. ... leading provider of software, strategic,consulting, and regulatory services ... global biopharmaceutical companies,have performed audits of its Reporting ...
... ... - Lead compound AEG40826 works synergistically with HGS TRAIL receptor ... -, - IAP inhibitors also show promise alone and in combination ... agents across broad range of cancers -, ROCKVILLE, Md. and MONTREAL, Quebec, ...
... 20 Human Genome,Sciences, Inc. (Nasdaq: HGSI ... patients in a Phase 2 clinical trial of ... and carboplatin as,first-line therapy in patients with advanced ... patients who are newly diagnosed with non-small cell,lung ...
Cached Biology Technology:Pharsight's Reporting and Analysis Services Business Reaches Quality Assurance Milestone 2Pharsight's Reporting and Analysis Services Business Reaches Quality Assurance Milestone 3Pharsight's Reporting and Analysis Services Business Reaches Quality Assurance Milestone 4Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 2Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 3Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 4Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 5Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 6Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 2Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 3Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 4Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 5Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy 6
(Date:8/27/2014)... Using functional near infrared spectroscopy (fNIRS), Kessler Foundation ... people with multiple sclerosis (MS) and healthy controls. ... brain activation was studied using fNIRS while participants ... cognition using functional near infrared spectroscopy (fNIRS) in ... by Brain Imaging and Behavior . Authors ...
(Date:8/27/2014)... 400 million years ago a group of fish began exploring ... and mammals. But just how these ancient fish used their ... evolutionary processes were at play remain scientific mysteries. , ... , turned to a living fish, called Polypterus , ... attempted to walk out of the water. Polypterus ...
(Date:8/27/2014)... is easier when it is related to ability that ... learn a new melody more easily than learning how ... the Center for the Neural Basis of Cognition (CNBC)a ... Mellon Universityhave discovered a fundamental constraint in the brain ... cover story in the Aug. 28, 2014, issue of ...
Breaking Biology News(10 mins):Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Walking fish reveal how our ancestors evolved onto land 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3
... PARK, MD, April 7, 2009 -- Roughly 20 percent ... homes, businesses, and other private and public spaces. Though ... also presents a tremendous opportunity for savings. Improving the ... little -- could translate into dramatically lower energy usage ...
... microbes that live within the plumbing of deep-sea mud ... resemble those in extraterrestrial environments and early Earth. The ... Foundation (NSF), was conducted in an area where clusters ... that support food chains independently of the Sun. ...
... researcher, Dr. Mark Flynn,s high-speed flywheel motor controller is ... the world. Flynn,s design has been incorporated into energy ... and sold by VYCON Inc. The 8,000 RTG ... significantly to port emissions and, as such, have ...
Cached Biology News:Cheap and efficient white light LEDs new design described in AIP's Journal of Applied Physics 2Cheap and efficient white light LEDs new design described in AIP's Journal of Applied Physics 3Better living through chemistry 2Better living through chemistry 3Saving energy and the environment with Flywheels 2
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
pETDuet-1 is designed for the coexpression of two target genes....
...
WIF-1 (N-20)...
Biology Products: